FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30933011000001102: Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    95556201000001110 Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    95556301000001118 Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Is a Alogliptin 12.5mg / Metformin 1g tablets false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has active ingredient Metformin false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has specific active ingredient Alogliptin benzoate false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has specific active ingredient Metformin hydrochloride false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Has basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) 56 tablet Has AMP False Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start